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  Carcinoma of the prostate is known to be one of the malignancies with much hazard for chcmo－
therapy． Thirty－seven patients mostly with hormone independent stage D carcinoma were collected
£rom 7 institutes， which were presented at the 4th Annual Meeting on Chemotherapy of Urological
Cancer．
  Although shortage of number of cases does not allow us to get to conclusions， cyclophosphamide
and cis－platinum are supposed to be effective agents as it has been previously reported in literature．
Special emphasis was placed on early decision of chemotherapy when the disease was judged to be
refractory from prQceedtng endocrine therapy．



























1332                泌尿紀要 27巻
る化学療法のみについてえられた結果を要約し，今後
の展望を混じえつつ幾つかの問題点を指摘してみた．
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CDDP ： eis－diammine dichloride platinum
PLM ： Peplemycin


























































































































































Peplomycin（PLM） 8 3 38
5－FV又はFutrafu1 4 o o
Estracyt 2 2 100
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